Genotropin
Cognition
The University of Texas Medical Branch, Galvestonprotein_peptidePhase 4 / ApprovedDormant
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 59/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Cognition cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Oxybutynin University of Alberta | Phase 4 | BBB |
Seroquel® Emory University | Phase 4 | BB |
Strattera Medical University of South Carolina | Phase 2 | BB |
S-Ketamine Peking University First Hospital | Phase 4 | BB |
Fingolimod Novartis Pharmaceuticals | Phase 4 | BB |
View all 20 →
Same molecule, other indications
Genotropin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →